Hanmi Pharmaceutical's Q2 Operating Profit Up 75% To KRW 58.1 Billion
Hanmi Pharmaceutical has achieved robust performance due to strong sales of key products and the growth of its…
Amosaltan
1 개의 기사가 있습니다.